X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-18 | SINT | Sintx Technologies, Inc. | Anderson Mark Lewis | Dir | P - Purchase | $3.02 | +3,000 | 18,000 | +20% | +$9,060 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Recupero Anthony J | See Remarks | S - Sale | $15.40 | -21,049 | 243,418 | -8% | -$324,204 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $15.35 | -20,756 | 285,974 | -7% | -$318,642 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $15.32 | -93,475 | 895,688 | -9% | -$1,432,122 | ||||||
2026-02-17 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.37 | -21,528 | 266,466 | -7% | -$330,982 | ||||||
2026-02-12 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.65 | -33,847 | 1,533,165 | -2% | -$55,848 | ||||||
2026-02-12 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.65 | -14,120 | 673,561 | -2% | -$23,298 | ||||||
2026-02-18 | CVRX | Cvrx, Inc. | Jain Mudit K. | Dir | P - Purchase | $4.64 | +600 | 939,033 | 0% | +$2,785 | ||||||
2026-02-18 | BDX | Becton Dickinson & Co | Scott Bertram L | Dir | S - Sale | $182.61 | -953 | 36,763 | -3% | -$174,027 | ||||||
| DM | 2026-02-12 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $23.51 | -60,000 | 43,298 | -58% | -$1,410,600 | |||||
| D | 2026-02-12 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $24.49 | -65,153 | 221,574 | -23% | -$1,595,486 | |||||
| D | 2026-02-12 | GMED | Globus Medical Inc | Huller Kelly | EVP, GC, Corporate Secretary | S - Sale+OE | $87.67 | -10,000 | 0 | -100% | -$876,700 | |||||
2026-02-12 | DXCM | Dexcom Inc | Heller Bridgette P | Dir | S - Sale | $68.01 | -1,012 | 26,019 | -4% | -$68,826 | ||||||
| DM | 2026-01-09 | STSS | Sharps Technology Inc. | Falconx Holdings Ltd | 10% | S - Sale+OE | $1.94 | -769,320 | 461,538 | -63% | -$1,490,755 | |||||
2026-02-13 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $100.26 | -1,000 | 21,000 | -5% | -$100,256 | ||||||
| D | 2026-02-11 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale+OE | $172.75 | -5,145 | 3,150 | -62% | -$888,796 | |||||
2026-02-10 | STIM | Neuronetics, Inc. | Macan William Andrew | EVP, CLO, CS | S - Sale | $1.55 | -3,485 | 687,681 | -1% | -$5,402 | ||||||
2026-02-10 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $1.55 | -40,976 | 1,567,012 | -3% | -$63,513 | ||||||
| DM | 2026-02-09 | PLSE | Pulse Biosciences, Inc. | Danahy Kevin Patrick | Chief Commercial Officer | S - Sale+OE | $23.39 | -60,000 | 43,298 | -58% | -$1,403,400 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $16.00 | +3,690,000 | 2,054,678 | -226% | +$59,040,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Behbahani Ali | Dir, 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Baskett Forest | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | New Enterprise Associates 17, L.P. | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Yang Rick | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Sandell Scott D | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Chang Carmen | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Walker Paul Edward | 10% | P - Purchase | $16.00 | +937,500 | 7,392,301 | +15% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Mathers Edward T | 10% | P - Purchase | $16.00 | +937,500 | 6,035,038 | +18% | +$15,000,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Pardo Geoffrey B | Dir | P - Purchase | $16.00 | +312,500 | 2,187,513 | +17% | +$5,000,000 | |||||
2026-02-09 | SGP | Spyglass Pharma, Inc. | Khan Bilal Arshad | Dir | P - Purchase | $16.00 | +135,000 | 276,877 | +95% | +$2,160,000 | ||||||
| D | 2026-02-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale+OE | $27.46 | -22,562 | 591,656 | -4% | -$619,553 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Nielsen Kirk G. | Dir | P - Purchase | $16.00 | +165,000 | 3,310,619 | +5% | +$2,640,000 | |||||
| D | 2026-02-09 | SGP | Spyglass Pharma, Inc. | Vensana Capital I Gp, LLC | 10% | P - Purchase | $16.00 | +165,000 | 3,310,619 | +5% | +$2,640,000 | |||||
| AD | 2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $169.97 | -20,519 | 21,422 | -49% | -$3,487,614 | |||||
| D | 2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $170.34 | -25,055 | 21,422 | -54% | -$4,267,869 | |||||
2026-02-09 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale | $169.97 | -20,519 | 21,422 | -49% | -$3,487,614 | ||||||
| D | 2026-02-09 | MMM | 3M Co | Chavez Rodriguez Beatriz Karina | Group Pres | S - Sale+OE | $171.13 | -1,190 | 19,859 | -6% | -$203,645 | |||||
| D | 2026-02-09 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $273.78 | -4,991 | 468,313 | -1% | -$1,366,436 | |||||
2026-02-05 | HTFL | Heartflow, Inc. | Cullivan Julie A | Dir | S - Sale | $27.32 | -8,000 | 36,413 | -18% | -$218,560 | ||||||
2026-02-05 | ATEC | Alphatec Holdings, Inc. | Sponsel David | EVP, Sales | S - Sale | $13.79 | -60,425 | 349,500 | -15% | -$833,261 | ||||||
| M | 2026-02-04 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $363.44 | -500,000 | 15,824,296 | -3% | -$181,719,269 | |||||
2026-02-04 | HTFL | Heartflow, Inc. | Bain Capital Life Sciences Investors, LLC | 10% | S - Sale | $28.05 | -2,000,000 | 10,448,158 | -16% | -$56,100,000 | ||||||
2026-02-04 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $251.31 | -2,000 | 64,773 | -3% | -$502,620 | ||||||
2026-02-04 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $260.00 | -50 | 9,691 | -1% | -$13,000 | ||||||
2026-02-03 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $14.71 | -37,358 | 1,173,025 | -3% | -$549,536 | ||||||
2026-02-02 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $16.42 | -337 | 90,085 | 0% | -$5,532 | ||||||
| D | 2026-02-02 | BSX | Boston Scientific Corp | Mahoney Michael F | COB, Pres, CEO | S - Sale+OE | $93.49 | -160,901 | 1,625,414 | -9% | -$15,043,394 | |||||
| D | 2026-02-02 | SYK | Stryker Corp | Pierce James Andrew | Group Pres | S - Sale+OE | $368.87 | -475 | 73,583 | -1% | -$175,215 | |||||
2026-02-02 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $257.03 | -1,000 | 85,495 | -1% | -$257,030 | ||||||
| M | 2026-01-15 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $1.62 | -61,194 | 1,139,177 | -5% | -$99,331 | |||||
2026-01-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, CRO, Pres Life Sciences | S - Sale | $202.73 | -75 | 16,431 | 0% | -$15,205 | ||||||
2026-01-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $100.65 | -5,000 | 4,487,950 | 0% | -$503,255 | ||||||
2026-01-26 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale | $15.57 | -2,943 | 225,681 | -1% | -$45,823 | ||||||
| D | 2026-01-22 | GKOS | Glaukos Corp | Stapley Marc | Dir | S - Sale+OE | $127.71 | -15,000 | 37,449 | -29% | -$1,915,576 | |||||
| D | 2026-01-22 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $127.68 | -10,498 | 92,366 | -10% | -$1,340,380 | |||||
| D | 2026-01-21 | GKOS | Glaukos Corp | Gilliam Joseph E | Pres, COO | S - Sale+OE | $124.65 | -4,502 | 92,366 | -5% | -$561,174 | |||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $6.62 | -4,836 | 1,912,273 | 0% | -$32,014 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $6.62 | -2,616 | 151,230 | -2% | -$17,318 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $6.62 | -22,362 | 6,025,840 | 0% | -$148,036 | ||||||
2026-01-16 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $6.62 | -6,308 | 267,611 | -2% | -$41,759 | ||||||
2026-01-16 | OFIX | Orthofix Medical Inc. | Andrews Julie | CFO | S - Sale | $14.38 | -4,873 | 58,039 | -8% | -$70,074 | ||||||
2026-01-20 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $101.85 | -5,000 | 4,492,950 | 0% | -$509,225 | ||||||
| DM | 2026-01-08 | GKOS | Glaukos Corp | Burns Thomas William | COB, CEO | S - Sale+OE | $115.00 | -275,000 | 1,605,814 | -15% | -$31,625,000 | |||||
| M | 2026-01-15 | STSS | Sharps Technology Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $2.32 | -37,182 | 1,511,988 | -2% | -$86,371 | |||||
2026-01-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $22.80 | -15,000 | 394,786 | -4% | -$342,024 | ||||||
| M | 2024-10-18 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.50 | +154,840 | 7,740,579 | +2% | +$77,999 | |||||
| DM | 2024-04-05 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.68 | +718,358 | 11,962,429 | +6% | +$485,355 | |||||
| D | 2023-12-15 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.90 | +111,112 | 1,859,363 | +6% | +$100,001 | |||||
| D | 2026-01-15 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale+OE | $207.46 | -1,610 | 12,095 | -12% | -$334,005 | |||||
| M | 2026-01-13 | STSS | Sharps Technology Inc. | Saba Capital Management, L.P. | 10% | S - Sale | $2.23 | -107,465 | 1,549,170 | -6% | -$240,010 | |||||
| M | 2026-01-09 | OFIX | Orthofix Medical Inc. | Calafiore Massimo | Pres, CEO | S - Sale | $15.52 | -19,397 | 217,237 | -8% | -$300,955 | |||||
| D | 2026-01-09 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $16.12 | -20,000 | 228,624 | -8% | -$322,400 | |||||
2026-01-12 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $97.45 | -5,000 | 4,497,950 | 0% | -$487,231 | ||||||
2026-01-08 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $21.28 | -20,000 | 90,422 | -18% | -$425,506 | ||||||
| D | 2026-01-08 | GMED | Globus Medical Inc | Kline Kyle | SVP, CFO | S - Sale+OE | $101.10 | -3,594 | 0 | -100% | -$363,353 | |||||
2026-01-08 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $101.10 | -2,000 | 10,419 | -16% | -$202,200 | ||||||
2026-01-09 | INSP | Inspire Medical Systems, Inc. | Rondoni John | See Remarks | S - Sale | $100.00 | -109 | 13,797 | -1% | -$10,900 | ||||||
2026-01-07 | RMD | Resmed Inc | Farrell Peter C | Dir | S - Sale | $248.83 | -2,000 | 66,773 | -3% | -$497,660 | ||||||
2026-01-06 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $312.64 | -186 | 8,230 | -2% | -$58,151 | ||||||
2026-01-06 | LYRA | Lyra Therapeutics, Inc. | Cavalier Jason | CFO | S - Sale | $3.36 | -769 | 518,547 | 0% | -$2,587 | ||||||
2026-01-06 | LYRA | Lyra Therapeutics, Inc. | Palasis Maria | Pres, CEO | S - Sale | $3.36 | -1,702 | 1,096,733 | 0% | -$5,726 | ||||||
| D | 2026-01-07 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $248.46 | -4,991 | 468,313 | -1% | -$1,240,065 | |||||
| D | 2026-01-06 | MMSI | Merit Medical Systems Inc | Peterson Neil W. | COO | S - Sale+OE | $90.00 | -5,000 | 28,369 | -15% | -$450,000 | |||||
2026-01-06 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $30.10 | -2,200 | 80,752 | -3% | -$66,221 | ||||||
2026-01-02 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $310.72 | -186 | 4,506 | -4% | -$57,794 | ||||||
| M | 2026-01-02 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $7.45 | -37,226 | 5,925,276 | -1% | -$277,183 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $7.77 | -11,170 | 245,420 | -4% | -$86,743 | |||||
| M | 2026-01-02 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $7.57 | -9,660 | 1,917,109 | -1% | -$73,148 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $7.78 | -4,999 | 153,846 | -3% | -$38,890 | |||||
| M | 2026-01-05 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $7.66 | -20,543 | 599,983 | -3% | -$157,366 | |||||
2026-01-06 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $7.48 | -619 | 170,212 | 0% | -$4,630 | ||||||
2026-01-05 | ATEC | Alphatec Holdings, Inc. | Miles Patrick | CEO | S - Sale | $21.01 | -100,000 | 5,396,298 | -2% | -$2,101,000 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $19.62 | -3,677 | 264,467 | -1% | -$72,144 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $19.62 | -3,460 | 228,436 | -1% | -$67,896 | ||||||
2026-01-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $19.64 | -5,229 | 180,002 | -3% | -$102,711 | ||||||
2026-01-02 | TCMD | Tactile Systems Technology Inc | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $28.85 | -5,139 | 72,401 | -7% | -$148,260 | ||||||
2026-01-05 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $97.68 | -5,000 | 4,502,950 | 0% | -$488,417 | ||||||
2026-01-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $29.61 | -7,800 | 82,952 | -9% | -$230,950 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |